Radiopharmaceutical Market Size, Share, Growth, and Industry Analysis, By Type (Technetium-99, Gallium-67, Iodine-123, 18F, Rubidium-82, Yttrium-90, Lutetium-177), By Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others), Regional Insights and Forecast to 2035
Detailed TOC of Global Radiopharmaceutical Market Trends Analysis Report 2026, Forecast to 2035
Table of Content1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Radiopharmaceutical Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Radiopharmaceutical Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Radiopharmaceutical Business Mode and Production Process
2.3.1 Radiopharmaceutical Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Radiopharmaceutical Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Radiopharmaceutical
2.4.2 Raw Material Cost of Radiopharmaceutical
2.4.3 Labor Cost of Radiopharmaceutical
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Radiopharmaceutical Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Radiopharmaceutical Price by Manufacturer (2021-2026)
4.4 Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Radiopharmaceutical, Product Offered and Application
4.7 Radiopharmaceutical Market Competitive Situation and Trends
4.7.1 Radiopharmaceutical Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Radiopharmaceutical Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Radiopharmaceutical Market Historical Development by Geographic Region (2021-2026)
5.1 Global Radiopharmaceutical Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Radiopharmaceutical Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Radiopharmaceutical Market Status by Country (2021-2026)
5.3.1 North America Radiopharmaceutical Sales Volume by Country (2021-2026)
5.3.2 North America Radiopharmaceutical Revenue by Country (2021-2026)
5.3.3 United States Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Radiopharmaceutical Market Status by Country (2021-2026)
5.4.1 Europe Radiopharmaceutical Sales Volume by Country (2021-2026)
5.4.2 Europe Radiopharmaceutical Revenue by Country (2021-2026)
5.4.3 Germany Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Radiopharmaceutical Market Status by Country (2021-2026)
5.5.1 Asia Pacific Radiopharmaceutical Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Radiopharmaceutical Revenue by Country (2021-2026)
5.5.3 China Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Radiopharmaceutical Market Status by Country (2021-2026)
5.6.1 Latin America Radiopharmaceutical Sales Volume by Country (2021-2026)
5.6.2 Latin America Radiopharmaceutical Revenue by Country (2021-2026)
5.6.3 Mexico Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Radiopharmaceutical Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Radiopharmaceutical Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2021-2026)
5.7.3 GCC Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Radiopharmaceutical Sales Volume, Revenue and Growth (2021-2026)
6 Global Radiopharmaceutical Market Historical Development by Product Type (2021-2026)
6.1 Radiopharmaceutical Definition by Type
6.2 Global Radiopharmaceutical Historical Sales Volume by Product Type (2021-2026)
6.3 Global Radiopharmaceutical Historical Revenue by Product Type (2021-2026)
6.4 Global Radiopharmaceutical Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Technetium-99 (2021-2026)
6.5.2 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Gallium-67 (2021-2026)
6.5.3 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Iodine-123 (2021-2026)
6.5.4 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of 18F (2021-2026)
6.5.5 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Rubidium-82 (2021-2026)
6.5.6 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Yttrium-90 (2021-2026)
6.5.7 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Lutetium-177 (2021-2026)
7 Global Radiopharmaceutical Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Radiopharmaceutical Historical Sales Volume by End User (2021-2026)
7.3 Global Radiopharmaceutical Historical Revenue by End User (2021-2026)
7.4 Global Radiopharmaceutical Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Ambulatory Surgical Centers (2021-2026)
7.5.3 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Diagnostic Centers (2021-2026)
7.5.4 Global Radiopharmaceutical Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 Life Molecular Imaging GmbH
8.1.1 Life Molecular Imaging GmbH Corporation Information
8.1.2 Life Molecular Imaging GmbH - Radiopharmaceutical Product Portfolio and Specification
8.1.3 Life Molecular Imaging GmbH Performance Analysis (2021-2026)
8.1.4 Life Molecular Imaging GmbH Business and Markets Served
8.1.5 Life Molecular Imaging GmbH Recent Developments
8.2 Bayer AG
8.2.1 Bayer AG Corporation Information
8.2.2 Bayer AG - Radiopharmaceutical Product Portfolio and Specification
8.2.3 Bayer AG Performance Analysis (2021-2026)
8.2.4 Bayer AG Business and Markets Served
8.2.5 Bayer AG Recent Developments
8.3 Ion Beam Applications SA (IBA)
8.3.1 Ion Beam Applications SA (IBA) Corporation Information
8.3.2 Ion Beam Applications SA (IBA) - Radiopharmaceutical Product Portfolio and Specification
8.3.3 Ion Beam Applications SA (IBA) Performance Analysis (2021-2026)
8.3.4 Ion Beam Applications SA (IBA) Business and Markets Served
8.3.5 Ion Beam Applications SA (IBA) Recent Developments
8.4 Eczacibasi-Monrol
8.4.1 Eczacibasi-Monrol Corporation Information
8.4.2 Eczacibasi-Monrol - Radiopharmaceutical Product Portfolio and Specification
8.4.3 Eczacibasi-Monrol Performance Analysis (2021-2026)
8.4.4 Eczacibasi-Monrol Business and Markets Served
8.4.5 Eczacibasi-Monrol Recent Developments
8.5 Lantheus Medical Imaging, Inc
8.5.1 Lantheus Medical Imaging, Inc Corporation Information
8.5.2 Lantheus Medical Imaging, Inc - Radiopharmaceutical Product Portfolio and Specification
8.5.3 Lantheus Medical Imaging, Inc Performance Analysis (2021-2026)
8.5.4 Lantheus Medical Imaging, Inc Business and Markets Served
8.5.5 Lantheus Medical Imaging, Inc Recent Developments
8.6 Telix Pharmaceuticals Limited
8.6.1 Telix Pharmaceuticals Limited Corporation Information
8.6.2 Telix Pharmaceuticals Limited - Radiopharmaceutical Product Portfolio and Specification
8.6.3 Telix Pharmaceuticals Limited Performance Analysis (2021-2026)
8.6.4 Telix Pharmaceuticals Limited Business and Markets Served
8.6.5 Telix Pharmaceuticals Limited Recent Developments
8.7 Eckert & Ziegler Group
8.7.1 Eckert & Ziegler Group Corporation Information
8.7.2 Eckert & Ziegler Group - Radiopharmaceutical Product Portfolio and Specification
8.7.3 Eckert & Ziegler Group Performance Analysis (2021-2026)
8.7.4 Eckert & Ziegler Group Business and Markets Served
8.7.5 Eckert & Ziegler Group Recent Developments
8.8 Blue Earth Diagnostics Limited
8.8.1 Blue Earth Diagnostics Limited Corporation Information
8.8.2 Blue Earth Diagnostics Limited - Radiopharmaceutical Product Portfolio and Specification
8.8.3 Blue Earth Diagnostics Limited Performance Analysis (2021-2026)
8.8.4 Blue Earth Diagnostics Limited Business and Markets Served
8.8.5 Blue Earth Diagnostics Limited Recent Developments
8.9 Curium Pharma
8.9.1 Curium Pharma Corporation Information
8.9.2 Curium Pharma - Radiopharmaceutical Product Portfolio and Specification
8.9.3 Curium Pharma Performance Analysis (2021-2026)
8.9.4 Curium Pharma Business and Markets Served
8.9.5 Curium Pharma Recent Developments
8.10 Bracco Diagnostics, Inc
8.10.1 Bracco Diagnostics, Inc Corporation Information
8.10.2 Bracco Diagnostics, Inc - Radiopharmaceutical Product Portfolio and Specification
8.10.3 Bracco Diagnostics, Inc Performance Analysis (2021-2026)
8.10.4 Bracco Diagnostics, Inc Business and Markets Served
8.10.5 Bracco Diagnostics, Inc Recent Developments
8.11 GE Healthcare
8.11.1 GE Healthcare Corporation Information
8.11.2 GE Healthcare - Radiopharmaceutical Product Portfolio and Specification
8.11.3 GE Healthcare Performance Analysis (2021-2026)
8.11.4 GE Healthcare Business and Markets Served
8.11.5 GE Healthcare Recent Developments
8.12 Alpha Tau Medical Ltd.
8.12.1 Alpha Tau Medical Ltd. Corporation Information
8.12.2 Alpha Tau Medical Ltd. - Radiopharmaceutical Product Portfolio and Specification
8.12.3 Alpha Tau Medical Ltd. Performance Analysis (2021-2026)
8.12.4 Alpha Tau Medical Ltd. Business and Markets Served
8.12.5 Alpha Tau Medical Ltd. Recent Developments
8.13 NTP Radioisotopes SOC Ltd
8.13.1 NTP Radioisotopes SOC Ltd Corporation Information
8.13.2 NTP Radioisotopes SOC Ltd - Radiopharmaceutical Product Portfolio and Specification
8.13.3 NTP Radioisotopes SOC Ltd Performance Analysis (2021-2026)
8.13.4 NTP Radioisotopes SOC Ltd Business and Markets Served
8.13.5 NTP Radioisotopes SOC Ltd Recent Developments
8.14 Clarity Pharmaceuticals
8.14.1 Clarity Pharmaceuticals Corporation Information
8.14.2 Clarity Pharmaceuticals - Radiopharmaceutical Product Portfolio and Specification
8.14.3 Clarity Pharmaceuticals Performance Analysis (2021-2026)
8.14.4 Clarity Pharmaceuticals Business and Markets Served
8.14.5 Clarity Pharmaceuticals Recent Developments
8.15 Cardinal Health, Inc
8.15.1 Cardinal Health, Inc Corporation Information
8.15.2 Cardinal Health, Inc - Radiopharmaceutical Product Portfolio and Specification
8.15.3 Cardinal Health, Inc Performance Analysis (2021-2026)
8.15.4 Cardinal Health, Inc Business and Markets Served
8.15.5 Cardinal Health, Inc Recent Developments
8.16 Orano Med
8.16.1 Orano Med Corporation Information
8.16.2 Orano Med - Radiopharmaceutical Product Portfolio and Specification
8.16.3 Orano Med Performance Analysis (2021-2026)
8.16.4 Orano Med Business and Markets Served
8.16.5 Orano Med Recent Developments
8.17 Advanced Accelerator Applications SA
8.17.1 Advanced Accelerator Applications SA Corporation Information
8.17.2 Advanced Accelerator Applications SA - Radiopharmaceutical Product Portfolio and Specification
8.17.3 Advanced Accelerator Applications SA Performance Analysis (2021-2026)
8.17.4 Advanced Accelerator Applications SA Business and Markets Served
8.17.5 Advanced Accelerator Applications SA Recent Developments
8.18 Siemens Healthineers
8.18.1 Siemens Healthineers Corporation Information
8.18.2 Siemens Healthineers - Radiopharmaceutical Product Portfolio and Specification
8.18.3 Siemens Healthineers Performance Analysis (2021-2026)
8.18.4 Siemens Healthineers Business and Markets Served
8.18.5 Siemens Healthineers Recent Developments
9 Global Radiopharmaceutical Market Forecast by Product Type and End User (2026-2035)
9.1 Global Radiopharmaceutical Market Forecast by Product Type (2026-2035)
9.1.1 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Technetium-99 (2026-2035)
9.1.2 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Gallium-67 (2026-2035)
9.1.3 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Iodine-123 (2026-2035)
9.1.4 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of 18F (2026-2035)
9.1.5 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Rubidium-82 (2026-2035)
9.1.6 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Yttrium-90 (2026-2035)
9.1.7 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Lutetium-177 (2026-2035)
9.2 Global Radiopharmaceutical Market Forecast by End User (2026-2035)
9.2.1 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2035)
9.2.2 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Ambulatory Surgical Centers (2026-2035)
9.2.3 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Diagnostic Centers (2026-2035)
9.2.4 Global Radiopharmaceutical Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2035)
10 Global Radiopharmaceutical Market Forecast by Geographic Region (2026-2035)
10.1 Global Radiopharmaceutical Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Radiopharmaceutical Sales Volume, Revenue Forecast and Growth (2026-2035)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer